NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 44 filers reported holding NEXTCURE INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $138,347 | -68.3% | 93,478 | -69.8% | 0.00% | – |
Q4 2022 | $436,739 | -52.8% | 309,744 | -7.9% | 0.00% | – |
Q3 2022 | $925,000 | -41.9% | 336,338 | -0.8% | 0.00% | – |
Q2 2022 | $1,593,000 | -12.1% | 339,008 | -9.1% | 0.00% | – |
Q1 2022 | $1,813,000 | -9.3% | 373,086 | +12.0% | 0.00% | – |
Q4 2021 | $1,999,000 | +197.0% | 333,128 | +233.6% | 0.00% | – |
Q3 2021 | $673,000 | -28.7% | 99,862 | -15.0% | 0.00% | – |
Q2 2021 | $944,000 | -56.1% | 117,553 | -45.3% | 0.00% | -100.0% |
Q1 2021 | $2,152,000 | -15.1% | 215,000 | -7.6% | 0.00% | 0.0% |
Q4 2020 | $2,536,000 | +110.5% | 232,677 | +70.0% | 0.00% | – |
Q3 2020 | $1,205,000 | -6.1% | 136,895 | +128.8% | 0.00% | – |
Q2 2020 | $1,283,000 | -41.7% | 59,821 | +0.9% | 0.00% | -100.0% |
Q1 2020 | $2,199,000 | +183.0% | 59,312 | +329.9% | 0.00% | – |
Q4 2019 | $777,000 | +256.4% | 13,797 | +95.5% | 0.00% | – |
Q3 2019 | $218,000 | – | 7,056 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |